CORC  > 复旦大学上海医学院
Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28
Tian, Chuan; Ying, Haifeng; Zhuang, Rongyuan; Zhang, Xiaowei; Lu, Hongmin; Wang, Hui; Wang, Shuowen; Li, Qi; Wang, Chungang; Cai, Xun
刊名CANCER MANAGEMENT AND RESEARCH
2018
卷号10
关键词irinotecan pharmacokinetics enzyme activity uridine diphosphate glucuronosyl-transferase 1A1 colorectal cancer
ISSN号1179-1322
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3610030
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Tian, Chuan,Ying, Haifeng,Zhuang, Rongyuan,et al. Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28[J]. CANCER MANAGEMENT AND RESEARCH,2018,10.
APA Tian, Chuan.,Ying, Haifeng.,Zhuang, Rongyuan.,Zhang, Xiaowei.,Lu, Hongmin.,...&Cai, Xun.(2018).Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28.CANCER MANAGEMENT AND RESEARCH,10.
MLA Tian, Chuan,et al."Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28".CANCER MANAGEMENT AND RESEARCH 10(2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace